The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•15 April 2026•

1 min read

Microbot Medical Launches LIBERTY Robotic System Fully in U.S. Following Strong Hospital Adoption

Key Facts

1Microbot Medical (MBOT) has begun the full U.S. launch of its LIBERTY robotic system.

Microbot Medical Inc. (MBOT) has initiated the full commercial launch of its LIBERTY robotic system in the United States, marking a significant operational milestone. This launch follows a period of successful early adoption by U.S. hospitals, which has provided positive momentum. The company is leveraging this strong clinical and institutional feedback to accelerate its market penetration strategy. The LIBERTY system is the company's flagship robotic surgical platform, designed to enhance procedural precision. Moving from limited release to a full-scale commercial rollout indicates growing confidence in the product's market fit. This development is expected to be a key driver for the company's near-term revenue growth and market positioning.